World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
53
Citations
10968
World Ranking
4075
National Ranking
153

Menzo J. E. Havenga publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Menzo J. E. Havenga sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 123 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Menzo J. E. Havenga D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Menzo J. E. Havenga sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 53 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Menzo J. E. Havenga is affiliated with Batavia Biosciences located in the Netherlands. Their research spans the fields of Biochemistry, Genetics and Molecular Biology as well as Medicine, with a specific focus on Molecular Biology, Genetics, Oncology, Cardiology and Cardiovascular Medicine, and Infectious Diseases.

The scientist's main research topics include virus-based gene therapy research, viral infectious diseases and gene expression in insects, CAR-T cell therapy research, viral infections and immunology research, viral gastroenteritis research and epidemiology, animal virus infections studies, and hermeneutics and narrative identity.

Menzo J. E. Havenga has contributed to several peer-reviewed publications. Selected recent papers include:

  • Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46, 2020, Proceedings of the National Academy of Sciences
  • Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective, 2022, Journal of Molecular Medicine
  • Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development, 2021, Journal of Virology
  • COVID-19: Transition to Online Problem-based Learning in Robotics - Challenges, Opportunities and Insights, 2020, Zenodo (CERN European Organization for Nuclear Research)
  • Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine, 2021, Vaccine

Co-authors frequently collaborating with Menzo J. E. Havenga include:

  • Wilfried A.M. Bakker
  • Mónika Z. Ballmann
  • Angelique A. C. Lemckert
  • Niklas Arnberg
  • Lijo John

The scientist publishes regularly in the following venues:

  • Vaccine
  • Proceedings of the National Academy of Sciences
  • Journal of Molecular Medicine
  • Journal of Virology
  • Zenodo (CERN European Organization for Nuclear Research)

Best Publications

  • Adenovirus serotype 5 hexon mediates liver gene transfer

    Simon N. Waddington;John H. McVey;David Bhella;Alan L. Parker

  • Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

    Peter Abbink;Angelique A. C. Lemckert;Bonnie A. Ewald;Diana M. Lynch

  • Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

    Diane M. Roberts;Anjali Nanda;Menzo J. E. Havenga;Peter Abbink

  • Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity

    Ronald Vogels;David Zuijdgeest;Richard van Rijnsoever;Eric Hartkoorn

  • Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys

    Jinyan Liu;Kara L. O’Brien;Diana M. Lynch;Nathaniel L. Simmons

  • Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity

    Dan H. Barouch;Maria G. Pau;Jerome H. H. V. Custers;Wouter Koudstaal

  • Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein

    Shawn M. Sumida;Diana M. Truitt;Angelique A. C. Lemckert;Ronald Vogels

  • Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

    M. J. E. Havenga;A. A. C. Lemckert;O. J. A. E. Ophorst;M. van Meijer

  • Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

    Delphine Rea;Menzo J. E. Havenga;Maayke van den Assem;Roger P. M. Sutmuller

  • Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.

    Katarina Radošević;Catharina W. Wieland;Ariane Rodriguez;Gerrit Jan Weverling

  • Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

    Shawn M. Sumida;Diana M. Truitt;Michael G. Kishko;Janelle C. Arthur

  • Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

    Mieke C. Sprangers;Wandena Lakhai;Wouter Koudstaal;Marielle Verhoeven

  • Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector.

    Stefan Kostense;Wouter Koudstaal;Mieke Sprangers;Gerrit Jan Weverling

  • Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

    Angelique A. C. Lemckert;Shawn M. Sumida;Lennart Holterman;Ronald Vogels

  • Adenoviruses Activate Human Dendritic Cells without Polarization toward a T-Helper Type 1-Inducing Subset

    Delphine Rea;Frederik H. E. Schagen;Rob C. Hoeben;Majid Mehtali

  • Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

    Lennart Holterman;Ronald Vogels;Remko van der Vlugt;Martijn Sieuwerts

  • Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells.

    M. Havenga;R. Vogels;D. Zuijdgeest;K. Radosevic

  • Improved adenovirus vectors for infection of cardiovascular tissues.

    M. J. E. Havenga;A. A. C. Lemckert;J. M. Grimbergen;R. Vogels

  • Complementing cell lines

    Ronald Vogels;Menzo Jans Emco Havenga;Majid Mehtali

  • Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys

    Jinyan Liu;Bonnie A. Ewald;Diana M. Lynch;Matthew Denholtz

Frequent Co-Authors

Jaap Goudsmit
Jaap Goudsmit Harvard University
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Paul H.A. Quax
Paul H.A. Quax Leiden University Medical Center
Simon N. Waddington
Simon N. Waddington University College London
Peter Abbink
Peter Abbink Harvard Medical School
John H. McVey
John H. McVey University of Surrey
Stuart A. Nicklin
Stuart A. Nicklin University of Glasgow
Andy Baker
Andy Baker University of New South Wales
Michelle A. Lifton
Michelle A. Lifton Beth Israel Deaconess Medical Center
Keith G. Mansfield
Keith G. Mansfield Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various related fields in healthcare and life sciences. Many students complement their microbiology background with specialized online programs to enhance career opportunities.

For those interested in the administrative and data management side of healthcare, exploring online health information management degree programs cahiim accredited offers a credible pathway. These programs train professionals to manage patient data effectively in clinical settings, a growing industry need.

If you're looking to enter the workforce quickly, taking a fast track medical billing and coding certificate online can provide valuable skills to secure positions in medical offices, insurance companies, and hospitals with minimal time investment.

Additionally, students aiming to expand their knowledge in healthcare management or public health may consider various online healthcare programs tailored to diverse career goals. These degrees offer flexibility without sacrificing quality education.

For those seeking advanced roles in public health, enrolling in some of the fastest and easiest online mph programs can facilitate timely advancement while balancing other commitments.

Best Scientists Citing Menzo J. E. Havenga

Trending Scientists